Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolidine effects on human blood cells
NL-OMON50878Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of taurolidine in catheter-associated bloodstream infection (CRBSI), sponsored by Radboud University Medical Center. Started Aug 2021; status: recruiting.
02
Drugs
taurolidine
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NL-OMON50878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50878.